about
Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsMechanisms of hemagglutinin targeted influenza virus neutralizationStructural basis for the divergent evolution of influenza B virus hemagglutininInhibition of influenza H7 hemagglutinin-mediated entryInfluenza virus neuraminidase (NA): a target for antivirals and vaccines.Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionFine epitope mapping of monoclonal antibodies against hemagglutinin of a highly pathogenic H5N1 influenza virus using yeast surface display.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized trial in Japanese children aged 6 months to 17 years.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine designA plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.Emerging antiviral strategies to interfere with influenza virus entry.Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle levelRe-engaging cross-reactive memory B cells: the influenza puzzle.Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals.Comparative structural analysis of haemagglutinin proteins from type A influenza viruses: conserved and variable features.Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.Dissection of antibody specificities induced by yellow fever vaccinationSelecting vaccine strains for H3N2 human influenza A virus.Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis.High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidaseUnraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.Traditional and new influenza vaccinesDefining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.An extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro.Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targetsEvasion of influenza A viruses from innate and adaptive immune responses.To dream the impossible dream: universal influenza vaccination.Advances and challenges in the development and production of effective plant-based influenza vaccines.In Silico Functional and Structural Characterization of H1N1 Influenza A Viruses Hemagglutinin, 2010-2013, Shiraz, Iran.Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines.The application of pseudotypes to influenza pandemic preparedness
P2860
Q26783107-421968E7-E9D5-4A8A-B302-F7466F2211D8Q27302234-0731BF48-C0BC-4095-B8D5-6182E7FCAED2Q27680083-9E09E43F-723F-49D5-A215-BBB0F464958AQ28534616-AAE0271D-2603-4E83-AD0C-DE4031D19C4DQ30249879-431307D7-8541-4725-B19D-CC7CDC7C45ECQ30360290-56F512D5-FCAF-40B9-BC94-1947F30729A5Q30369470-CF088530-BC2C-4E69-8BCF-392DEA2F611AQ30371674-0FB4BB16-B256-432D-9063-B42BB00ED435Q30402648-95C13BC9-3B85-4EF2-82A3-131D28981367Q30403507-EE0CD194-5547-4FD9-8484-3C4A235D7469Q30414384-382041A6-BB9A-4EA5-831C-79A165278C41Q30415263-1F1660D2-8D4A-40A7-8947-081BA7440D54Q30416502-F5FBF0D7-BEE9-46D6-B808-0265266D9ACAQ30425590-F7FE5553-5C60-46C1-A509-4AF37F333BF7Q30432421-8DB14895-EF15-4BBE-88C7-C79581E1AA8BQ30516488-74F860CD-9ADA-472D-BF48-8EAD11D3A2B4Q30606286-347A45F4-C0F9-41B0-9938-3569E2BE11BEQ33353517-96DB85BA-1E4D-4787-94AC-7DA6F49BA1B4Q33553746-2FEBFCA3-CD83-41CA-AB63-D3C69584F16DQ33809686-BCE68071-2E81-4A6E-8674-9191DE3F5273Q34694454-3E17F409-5FDA-4C59-9754-F696BD4AE314Q34770423-B31710C0-DDE6-4DF0-B6D1-2A2F219587C7Q34789343-22DE8157-FC89-4025-8802-DA07B5DA3815Q35350500-E84EABC1-F332-4F99-8094-7C0EADA4AFAFQ35650895-E38A08D0-FB37-4EBA-8ADE-07B8B0C8C647Q35826733-99D98A83-C228-418F-AFE9-DED9AA029592Q36208249-915C9226-F39E-4D02-9FBA-969B0F237343Q36344790-A19BB0CD-FFDC-45E4-80D2-2DA9D407EBEBQ36452689-66145696-5C21-45F8-9E55-75F6647193FCQ36667857-45A34805-384F-4A1D-980D-7841249D4635Q37035833-17B8A333-40E5-4AA9-955F-0D32C179B96EQ37104756-C14BE16A-94D6-4A7C-ADEE-2F7BD2B4EFA0Q37379463-59C07856-E0AA-4C9A-BA55-05988327FF29Q37698939-F907867D-FA11-49D1-98FE-4C440FC8D3D0Q38061423-31F2E60F-A752-429A-9B4E-156DA81CD1AFQ38120113-CEBB5DF6-2B68-430D-BDD8-35A73E2906DFQ38285425-2D57A617-AA48-417F-8EBA-17E31F9C3D37Q41745430-3066CB14-3AF3-4701-813B-3522A834ED4EQ42202779-DC7DF61F-74AB-4FC2-8DC4-C2522BDB5A5AQ58382401-9E2D0E70-1FDC-4B90-A955-FE29D7233979
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Structural basis of influenza virus neutralization.
@ast
Structural basis of influenza virus neutralization.
@en
type
label
Structural basis of influenza virus neutralization.
@ast
Structural basis of influenza virus neutralization.
@en
prefLabel
Structural basis of influenza virus neutralization.
@ast
Structural basis of influenza virus neutralization.
@en
P2860
P1476
Structural basis of influenza virus neutralization.
@en
P2093
Thomas Han
Wayne A Marasco
P2860
P304
P356
10.1111/J.1749-6632.2010.05829.X
P407
P577
2011-01-11T00:00:00Z